IPAMORELIN — 10 MG

Description

DESCRIPTION

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as a selective ghrelin receptor agonist. It is studied in research models for receptor binding, downstream growth hormone axis signaling, and selectivity relative to other secretagogues.

RESEARCH AREAS

• Ghrelin receptor agonism — studied in cell-based assays for receptor binding and pathway activation.
• GH axis signaling — investigated in preclinical models for stimulation of pituitary GH release.
• Selectivity profile — characterized in published research for minimal activity at ACTH, cortisol, and prolactin pathways.
• Comparative secretagogue research — studied alongside other GH secretagogue compounds.

WHAT RESEARCHERS LOOK AT

• Mechanism: selective ghrelin receptor (GHS-R1a) agonism.
• Selectivity profile versus other secretagogue research compounds.
• Synergistic activity with GHRH analog research compounds.
• Applications in GH axis and pituitary research models.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 10 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Formula / M.W.: C38H49N9O5, ~711.9 g/mol
• CAS: 170851-70-4

SELECTED RESEARCH

• PubChem entry — chemical identity:
  https://pubchem.ncbi.nlm.nih.gov/compound/16132392
• Selective GH release profile study (1998):
  https://pubmed.ncbi.nlm.nih.gov/9691368/
• Comparison to other GHS compounds (2002):
  https://pubmed.ncbi.nlm.nih.gov/12107229/
• GH axis synergy with GHRH analogs (2004):
  https://pubmed.ncbi.nlm.nih.gov/15240392/

⚠️ DISCLAIMER

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.